BIIB Financial Facts
Other income (expense), net: -7.73MBasic earnings per share attributable to Biogen Idec Inc.: 242.88M
See Full Income Statement
Long-term deferred tax liability: 238.18M
Taxes payable: 47.98M
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +5.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/26/22 | Q222 | N/A | $4.11 | N/A | N/A | $2.49B | N/A | N/A | N/A | ||
| 5/3/22 |  |
Q122 | $3.62 | $4.38 | -$0.76 | $2.53B | $2.5B | N/A |  | | Details |
| 2/3/22 | |
Q421 | $3.39 | $3.40 | -$0.01 | $2.73B | $2.62B | N/A | | | Details |
10/20/21  |
Q321 | $4.77 | $4.11 | +$0.66 | $2.78M | $2.67M | N/A | | | Details | |
| 7/22/21 | |
Q221 | $5.68 | $4.55 | +$1.13 | $2.78B | $2.61B | N/A | | | Details |
| 4/22/21 | Q121 | $5.34 | $5.04 | +$0.30 | $2.69B | $2.65B | N/A | | | Details | |
| 2/3/21 |
Q420 | $4.58 | $4.87 | -$0.29 | $2.85M | $2.8M | N/A | | | Details | |
| 10/21/20 | |
Q320 | $8.84 | $8.13 | +$0.71 | $3.38B | $3.35B | N/A | | | Details |
